Carole Morel, PhD

Research Associate

Dr. Morel received her BA in Integrated Biology from the University of Orleans and her PhD in Neurosciences from the University of Pierre and Marie Curie (Sorbonne University) in Paris. Her research focused on identifying potent pharmacological targets for drugs of abuse and psychiatric disorders. She then joined the Icahn School of Medicine at Mount Sinai, where she led and managed projects exploring and targeting the molecular and cellular underpinnings of mood disorders and neurodegenerative brain diseases. In addition to her research, Dr. Morel has regularly been involved in several public health and science education outreach projects and is actively engaging in mentorship programs to cultivate the next generation of scientists.

Linkedin

inThought Research empowers biopharma leaders with comprehensive strategic insights. We combine Wall Street financial acumen and swiftness, scientific expertise, and advanced AI analytics to navigate the complex landscape of drug development.

Linkedin
Quick Links
Get In Touch
Our Family Of Companies​
inThought Labs logo

Privacy Policy

Terms of Service

Services

Vulnerability

© 2024 inThought Research. All Rights Reserved.

Contact us

Learn how inThought Labs can simplify your life and empower your team with expert consultants and our cloud-based system, inVision.

Chris Martin

President

As the president of inThought Labs, Chris is focused on constantly improving inVision, the leading competitive and market intelligence platform for the biopharmaceutical industry, to better meet the changing needs of clients.

 

With 20 years of experience in roles being a consumer of market and competitive information, Chris understands the needs and priorities of clients. Chris was a senior principal and co-founder of inThought, a life science consulting, market research, and analytics firm. Collaborating with Ben Weintraub, Chris also co-founded BiotechTracker, an online tool for investors and precursor to inVision. Previous to inThought, he was a healthcare analyst and co-portfolio manager at two investment firms. Chris served in health care policy roles at the White House Office of Management and Budget. These roles included Medicare Desk Officer at the Office of Information and Regulatory Affairs, where he was responsible for providing recommendations to senior White House policy officials on healthcare policies and regulations.

 

Chris has a Master in Business Administration from Harvard Business School, a Master in Engineering from Villanova University, and a Bachelor of Science in Engineering from Cornell University. Prior to attending Harvard Business School, Chris served on two U.S. Navy nuclear submarines and at the Pentagon.